Client Reported $ Filings Share
MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) $460.0K 3
BICYCLE THERAPEUTICS $300.0K 3
ALKERMES, INC. $210.0K 3
AVADEL PHARMACEUTICALS, PLC $180.0K 3
REGENXBIO INC. $180.0K 3
ALNYLAM PHARMACEUTICALS, INC. $170.0K 3
INCYTE CORPORATION $170.0K 3
GLAXOSMITHKLINE LLC $150.0K 3
PTC THERAPEUTICS, INC. $150.0K 3
SAVARA INC. $150.0K 4
STEALTH BIOTHERAPEUTICS INC. $150.0K 3
HARMONY BIOSCIENCES $130.0K 3
IONIS PHARMACEUTICALS, INC. $120.0K 3
NEUROPACE, INC. $110.0K 3
ARDELYX, INC. $90.0K 3
ERISA INDUSTRY COMMITTEE (ERIC) $90.0K 3
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA $90.0K 3
MEDICAL DEVICE MANUFACTURERS ASSOCIATION $60.0K 3
REZOLUTE, INC. $40.0K 2
ACADIA PHARMACEUTICALS $30.0K 2
BIOMARIN PHARMACEUTICAL, INC. $30.0K 2
EXELIXIS, INC. $30.0K 2
NEUROCRINE BIOSCIENCES, INC. $30.0K 2
TRAVERE THERAPEUTICS, INC. $30.0K 3
INSMED INCORPORATED $20.0K 2
NATERA, INC. $20.0K 1
UNIVERSITY OF LOUISVILLE HEALTH $20.0K 2

3 of 5 lobbyists (60%) listed a prior covered government position on a lobbying filing.

AMY EFANTIS
Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett
SOPHIE KHANAHMADI
Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions
ALANNA TEMME
Legislative Director, U.S. Representative Jon Porter

3 reports on file for 2025 (latest version of each); 2 reported no contributions.

Itemized by year

Largest recipients, 2025

Posted Period Client Type Income Expenses Activities Lobbyists
2026-04-17 2026 Q1 STEALTH BIOTHERAPEUTICS INC. 1st Quarter - Report $60.0K — 2 4
2026-04-17 2026 Q1 SAVARA INC. 1st Quarter - Report $60.0K — 2 3
2026-04-17 2026 Q1 REGENXBIO INC. 1st Quarter - Report $60.0K — 2 3
2026-04-17 2026 Q1 PTC THERAPEUTICS, INC. 1st Quarter - Report $50.0K — 1 4
2026-04-17 2026 Q1 NEUROPACE, INC. 1st Quarter - Report $30.0K — 1 4
2026-04-17 2025 Q4 NEUROCRINE BIOSCIENCES, INC. 4th Quarter - Termination $30.0K — 2 1
2026-04-17 2026 Q1 MEDICAL DEVICE MANUFACTURERS ASSOCIATION 1st Quarter - Report $20.0K — 2 3
2026-04-17 2026 Q1 IONIS PHARMACEUTICALS, INC. 1st Quarter - Report $30.0K — 1 4
2026-04-17 2026 Q1 INCYTE CORPORATION 1st Quarter - Report $50.0K — 2 3
2026-04-17 2026 Q1 HARMONY BIOSCIENCES 1st Quarter - Report $50.0K — 1 3
  • AMY EFANTIS · prior govt
  • SONIA GOH
  • SOPHIE KHANAHMADI · prior govt
  • ALANNA TEMME · prior govt
  • MAXIMILIAN WALTER

Source: LDA.gov, data retrieved October 31, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.